Detalhe da pesquisa
1.
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype.
Br J Haematol
; 198(6): 1011-1015, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802024
2.
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.
Br J Haematol
; 193(4): 792-797, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751548
3.
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia.
Br J Haematol
; 194(6): 999-1006, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085278
4.
Bone marrow niche dysregulation in myeloproliferative neoplasms.
Haematologica
; 105(5): 1189-1200, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241851
5.
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
Am J Hematol
; 95(2): 156-166, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721282
6.
Essential thrombocythaemia treated with recombinant interferon: 'real world' United Kingdom referral centre experience.
Br J Haematol
; 186(4): 561-564, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31090926
7.
Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review.
Haematologica
; 104(8): 1580-1588, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30679326
8.
What is pre-fibrotic myelofibrosis and how should it be managed in 2018?
Br J Haematol
; 183(1): 23-34, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30328618
9.
An updated review of the JAK1/2 inhibitor (ruxolitinib) in the Philadelphia-negative myeloproliferative neoplasms.
Future Oncol
; 14(2): 137-150, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29056075
10.
Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19.
Am J Hematol
; 97(12): E470-E473, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111658
11.
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Br J Haematol
; 193(4): 692-696, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33719038
12.
A team-based multidisciplinary approach to managing peripherally inserted central catheter complications in high-risk haematological patients: a prospective study.
Support Care Cancer
; 24(1): 93-101, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25935657
13.
Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm-associated venous thromboembolism in a large tertiary centre in the UK.
Br J Haematol
; 189(3): e79-e81, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32011726
14.
Polycythemia Vera: Barriers to and Strategies for Optimal Management.
Blood Lymphat Cancer
; 13: 77-90, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146420
15.
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis.
J Clin Oncol
; 41(32): 4993-5004, 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881782
16.
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
J Clin Oncol
; 41(19): 3534-3544, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126762
17.
Thiamine deficiency appears uncommon in patients with Myeloproliferative Neoplasms.
Br J Haematol
; 178(2): 338-340, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27135305
18.
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs.
Blood Adv
; 6(17): 5171-5183, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802458
19.
Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021.
Hemasphere
; 5(7): e609, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34179698
20.
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.
Leukemia
; 35(2): 485-493, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33414483